Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

SG&A Expenses

$63.98M

Quarterly · Period ending: Jun 30, 2026 · USD

BCRX SG&A Expenses

Latest reported$63.98Mperiod endingJun 30, 2026

Latest reported$63.98Mperiod endingJun 30, 2026

BCRX Quarterly SG&A Expenses ($500.00K → $63.98M)

Quarterly SG&A Expenses

High-resolution chart · PNG

BCRX sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc SG&A Expenses — Quarterly (USD)
Period ending	SG&A Expenses (USD)
Jun 30, 2001	865,000
Mar 31, 2001	739,000
Dec 31, 2000	944,256
Sep 30, 2000	709,000
Jun 30, 2000	877,000
Mar 31, 2000	1,427,619
Dec 31, 1999	600,000
Sep 30, 1999	700,000
Jun 30, 1999	900,000
Mar 31, 1999	800,000
Dec 31, 1998	600,000
Sep 30, 1998	1,200,000
Jun 30, 1998	700,000
Mar 31, 1998	600,000
Dec 31, 1997	600,000
Sep 30, 1997	500,000
Jun 30, 1997	1,000,000
Mar 31, 1997	700,000
Dec 31, 1996	600,000
Sep 30, 1996	500,000
Jun 30, 1996	1,100,000
Mar 31, 1996	500,000
Dec 31, 1995	700,000
Sep 30, 1995	500,000
Jun 30, 1995	500,000
Mar 31, 1995	600,000
Dec 31, 1994	400,000
Sep 30, 1994	400,000
Jun 30, 1994	600,000
Mar 31, 1994	500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.